Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
CareDx ( (CDNA) ) just unveiled an announcement.
CareDx, Inc. announced amendments to its outside director compensation policy, which include changes to the vesting schedules for stock options and restricted stock unit awards for non-employee directors, ensuring full vesting before the annual stockholders’ meeting if it occurs before the one-year anniversary of the award. Additionally, the company removed quarterly retainers for Michael Goldberg, the Board Chairperson, for his previous role in the Office of the CEO, and updated outdated references to an older equity plan.
More about CareDx
CareDx, Inc. operates in the healthcare industry, focusing on providing diagnostic solutions and services for transplant patients.
YTD Price Performance: 5.58%
Average Trading Volume: 800,313
Technical Sentiment Consensus Rating: Hold
Current Market Cap: $1.25B
See more data about CDNA stock on TipRanks’ Stock Analysis page.
